Poly(lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: Some novel findings

Toxicology and Applied Pharmacology

Volumn 267, Issue 1, 2013, Pages 57-73

  Samadder, Asmita ^a   Das, Jayeeta ^a   Das, Sreemanti ^a   De, Arnab ^a   Saha, Santu Kumar ^a   Bhattacharyya, Soumya Sundar ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Arsenic induced hyperglycemia; Circular dichroic spectra; Mice; Mitochondria; PLGA; Transmission and atomic force microscopy

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARSENIC; CALCIUM; CASPASE 3; CYTOCHROME C; CYTOCHROME P450 1A1; GLUCOKINASE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; NANOINSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYGLACTIN; PROTEIN BCL 2; PYRUVATE KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CELL MEMBRANE POTENTIAL; CIRCULAR DICHROISM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG RELEASE; DRUG STRUCTURE; FEMALE; HYPERGLYCEMIA; LIGHT SCATTERING; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; ZETA POTENTIAL;

ANIMALS; ARSENIC; BLOOD-BRAIN BARRIER; DRUG CARRIERS; FEMALE; HYPERGLYCEMIA; INSULIN; LACTIC ACID; MALE; MICE; NANOPARTICLES; POLYGLYCOLIC ACID; RANDOM ALLOCATION;

MUS;

EID: 84872258365     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.12.018     Document Type: Article

References (64)

1. Anand P., Nair H.B., Sung B., Kunnumakkara A.B., Yadav V.R., Tekmal R.R., Aggarwal B.B. Design of curcumin loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 2009, 10217:1-9.
2. Andrew C., Cornish-Bowden S., Cornish-Bowden A. The kinetics of coupled enzyme reactions - applications to the assay of glucokinase, with glucose-6-phosphate-dehydrogenase as coupling enzyme. Biochem. J. 1974, 141:205-209.
3. Ankola D.D., Viswanad B., Bhardwaj V., Ramarao P., Kumar M.N. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?. Eur. J. Pharm. Biopharm. 2007, 67:361-369.
4. Banerjee P., Biswas S.J., Belon P., Khuda-Bukhsh A.R. A potentized homeopathic drug, Arsenicum Album 200, can ameliorate genotoxicity induced by repeated injections of arsenic trioxide in mice. J. Vet. Med. A 2007, 54:370-376.
5. Belon P., Banerjee P., Choudhury S.C., Banerjee A., Biswas S.J., Karmakar S.R., Pathak S., Guha B., Chatterjee S., Bhattacharjee N., Das J.K., Khuda-Bukhsh A.R. Can administration of potentized homeopathic remedy, Arsenicum album, alter antinuclear antibody (ANA) titer in people living in high-risk arsenic contaminated areas? I. A correlation with certain hematological parameters. Evid. Based Complement. Alternat. Med. 2006, 3:99-107.
6. Bhattacharyya S.S., Paul S., Khuda-Bukhsh A.R. Encapsulated plant extract (Gelsemium sempervirens) PLGA nanoparticles enhance cellular uptake and increase bioactivity in vitro. Exp. Biol. Med. 2010, 235:678-688.
7. Bhattacharyya S.S., Paul S., De A., Das D., Samadder A., Boujedaini N., Khuda-Bukhsh A.R. Poly(lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target. Toxicol. Appl. Pharmacol. 2011, 253:270-281.
8. Biswas S.J., Bhattacharyya N., Khuda-Bukhsh A.R. Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food Chem. Toxicol. 2008, 46:1474-1487.
9. Biswas R., Mandal S.K., Dutta S., Bhattacharyya S.S., Boujedaini N., Khuda-Bukhsh A.R. Thujone-rich fraction of Thuja occidentalis demonstrates major anti-cancer potentials: evidences from in vitro studies on A375 cells. eCAM 2010, 10.1093/ecam/neq042.
10. Bojunga J., Nowak D., Mitrou P.S., Hoelzer D., Zeuzem S., Chow K.U. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 2004, 2072-2080.
11. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 1973, 19:476-482.
12. Bunn H.F. Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes 1981, 30:613-617.
13. Burnette W.N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radio iodinated protein. Anal. Biochem. 1981, 112:195-203.
14. Chapman M.J. Metabolic syndrome and type 2 diabetes: lipid and physiological consequences. Diab. Vasc. Dis. Res. 2007, 4:S5-S8.
15. Cherrington A.D., Sindelar D., Edgerton D., Steiner K., McGuinness O.P. Physiological consequences of phasic insulin release in the normal animal. Diabetes 2002, 51:S103-S108.
16. Das S.C. Advanced Practical Chemistry, Inorganic Quantitative Analysis 2009, 268-273. Subhasis Das.
17. De Rosa G., Larobina D., La Rotonda M.I., Musto P., Quaglia F., Ungaro F. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system. J. Control. Release 2005, 102:71-83.
18. Delnomdedieu M., Basti M.M., Styblo M., Otvos J.D., Thomas D.J. Complexation of arsenic species in rabbit erythrocytes. Chem. Biol. Interact. 1994, 98:69-83.
19. Dhiman R., Kathania M., Raje M., Majumder S. Inhibition of bf1-1/A1 by SiRNA inhibits mycobacterial growth in THF-1 cells by enhancing phagosomal acidification. Biochim. Biophys. Acta 2008, 1780:733-742.
20. Diaz-Villasenor A., Sanchez-Soto M.C., Cebrian M.E., Ostrosky-Wegman P., Hiriart M. Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol. Appl. Pharmacol. 2006, 214:30-34.
21. Fessi H., Puisieux F., Devissaquet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989, 55:1-4.
22. Frezza C., Cipolat S., Scorrano L. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2007, 2:287-295.
23. Fröde T.S., Medeiros Y.S. Animal models to test drugs with potential antidiabetic activity. J. Ethnopharmacol. 2008, 115:173-183.
24. Gale E.A., Gillespie K.M. Diabetes and gender. Diabetologia 2001, 44:3-15.
25. Hasselbalch S.G., Knudsen G.M., Capaldo B., Postiglione A., Paulson O.B. Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J. Clin. Endocrinol. Metabol. 2001, 86:1986-1990.
26. Ishmukhametov R.R., Pond J.B., Al-Huqail A., Galkin M.A., Vik S.B. ATP synthesis without R210 of subunit a in the Escherichia coli ATP synthase. Biochim. Biophys. Acta 2008, 1777:32-38.
27. Izquierdo-Vega J.A., Soto C.A., Sanchez-Penta L.C., De Vizcaya-Ruiz A., Del Razo L.M. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol. Lett. 2006, 160:135-142.
28. Jaburek M., Vareeha M., Gimeno R.E., Dembski M., Jezek P., Zhang M., Burn P., Tartaglia L.A., Garlid K.D. Transport function and regulation of mitochondrial uncoupling protein 2 and 3. J. Biol. Chem. 1999, 274:260003-260007.
29. Jones F.T. A broad view of arsenic. Poult. Sci. 2007, 86:2-14.
30. Jones C.F., Grainger D.W. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 2009, 61:438-456.
31. Kaplan L.A. Carbohydrates and metabolite. Clin. Chem. 1984, 1032-1040.
32. Kaplan A., Lavernel L.S. Lipid metabolism. Clinical Chemistry: Interpretations and Techniques 1983, 333-336. Lea and Febiger, Philadelphia. 2nd ed.
33. Karakoti A.S., Hench L.L., Seal S. The potential toxicity of nanomaterials - the role of surfaces. JOM 2006, 58:77-82.
34. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
35. Khuda-Bukhsh A.R., Bhattacharyya S.S., Paul S., Dutta S., Boujedaini N., Belon P. Modulation of signal proteins: a plausible mechanism to explain how a potentized drug Secale Cor 30C diluted beyond Avogadro's limit combats skin papilloma in mice. eCAM 2011, 10.1093/ecam/nep084.
36. Kodama S., Koike C., Negishi M., Yamamoto Y. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 2004, 24:7931-7940.
37. Krauss S., Zhang C.Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grey S.T., Lowell B.B. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J. Clin. Invest. 2003, 112:1831-1842.
38. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 1994, 139:484-492.
39. Le-Roith D., Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001, 24:588-597.
40. Liu S., Okada T., Assmann A., Soto J., Liew C.W., Bugger H., Shirihai O.S., Abel E.D., Kulkarni R.N. Insulin signaling regulates mitochondrial function in pancreatic b-cells. PLoS One 2009, 4(11):e7983. 10.1371/journal.pone.0007983.
41. Longnecker M.P., Daniels J.L. Environmental contaminants as etiologic factors for diabetes. Environ. Health Perspect. 2001, 109:871-876.
42. Maechler P., Woheim C.B. Mitochondrial function in normal and diabetic ß-cells. Nature 2001, 414:807-812.
43. Manna P., Sinha M., Sil P.C. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch. Toxicol. 2008, 82:137-149.
44. Massague J., Pilch P.F., Czech M.P. Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc. Natl. Acad. Sci. 1980, 77:7137-7141.
45. Mazurek S., Grimm H., Boschek C.B., Vaupel P., Eigenbrodt E. Pyruvate kinase type M2: a crossroad in the tumor metabolome. Br. J. Nutr. 2002, 87:23-29.
46. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Burke T.A., Guallar E. Arsenic exposure and Type 2 diabetes: a systemic review of experimental and epidemiological evidence. Environ. Health Perspect. 2006, 114:641-648.
47. Panja S., Saha S., Jana B., Basu T. Role of membrane potential on artificial transformation of E. coli with plasmid DNA. J. Biotechnol. 2006, 127:14-20.
48. Parat A., Danicher L., Frère Y., Reix N., Seyfritz E., Sigrist S. Double encapsulation of insulin: a new pharmaceutical vector for oral route. XVIIth International Conference on Bioencapsulation, Groningen, The Netherlands 2009.
49. Paul D.S., Harmon A.W., Devesa V., Thomas D.J., Styblo M. Molecular mechanisms of diabetogenic effects of arsenic:inhibition of insulin signaling by arsenite and methylarsonous acid. Environ. Health Perspect. 2007, 115:734-742.
50. Paul P., Bhattacharyya S.S., Samaddar A., Boujedaini N., Khuda-Bukhsh A.R. Anticancer potentials of root extract of Polygala senega against benzo[a] pyrene-induced lung cancer in mice. J. Chin. Integr. Med. 2011, 9:320-327.
51. Rahban M., Divsalar A., Saboury A.A., Golestani A. Nanotoxicity and spectroscopy studies of silver nanoparticles: calf thymus DNA and K562 as targets. J. Phys. Chem. 2010, 114:5798-5803.
52. Ratha J., Majumder K.N., Mandal S.K., Bera R., Sarkar C., Saha B., Mandal C., Saha K.D., Bhadra R. A sphingolipid rich lipid fraction isolated from attenuated donovani promastigote induces apoptosis in mouse and human melanoma cells in vitro. Mol. Cell. Biochem. 2006, 290:113-123.
53. Rosen B.P. Biochemistry of arsenic detoxification. FEBS Lett. 2002, 529:86-92.
54. Samadder A., Chakraborty D., De A., Bhattacharyya S.S., Bhadra K., Khuda-Bukhsh A.R. Possible signaling cascades involved in attenuation of alloxan-induced oxidative stress and hyperglycemia in mice by ethanolic extract of Syzygium jambolanum: drug-DNA interaction with calf thymus DNA as target. Eur. J. Pharm. Sci. 2011, 44:207-217.
55. Samadder A., Das J., Das S., Das D., De A., Bhadra K., Khuda-Bukhsh A.R. Dihydroxy-isosteviol methyl ester of Pulsatilla nigricans extract reduces arsenic- induced DNA damage in testis cells of male mice: its toxicity, drug-DNA interaction and signalling cascades. Zhong Xi Yi Jie He Xue Bao 2012, 10:1433-1442.
56. Schafer Z.T., Grassian A.R., Song L., Jiang Z., Hines Z.G., Irie H.Y., Gao S., Puigserver P., Brugge J.S. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113.
57. Sinha M., Manna P., Sil P.C. Protective effect of arjunolic acid against arsenic induced oxidative stress in mouse brain. J. Biochem. Mol. Toxicol. 2008, 22:15-26.
58. Smelt M.J., Faas M.M., de Haan B.J., de Vos P. Pancreatic beta-cell purification by altering FAD and NAD (P)H metabolism. Exp. Diabetes Res. 2008, 10.1155/2008/165360.
59. Tseng C.H. The potential biological mechanisms of arsenic induced diabetes mellitus. Toxicol. Appl. Pharmacol. 2004, 197:67-83.
60. Vahter M., Åkesson A., Lidén C., Seccatelli S., Berglund M. Gender differences in the disposition and toxicity of metals. Environ. Res. 2007, 104:85-95.
61. Weissenböck A., Wirth M., Gabor F. WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells. J. Control. Release 2004, 99:383-392.
62. Wullschleger S., Wasserman D.H., Gray A., Sakamoto K., Alessi D.R. Role of TAPP1 and TAPP2 adaptors binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis. Biochem. J. 2011, 434:265-274.
63. Zheng J., He J., Ji B., Li Y., Zhang X. Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pac. J. Clin. Nutr. 2007, 16:427-431.
64. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.